Navigation Links
Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
Date:3/22/2012

GOTHENBURG, Sweden, March 22, 2012 /PRNewswire/ --

The new Dynaflow Resolve System was developed in close collaboration with leading ion-channel research groups to meet the demand for a simpler technology capable of complex perfusion protocols. The Dynaflow Resolve System is an advanced automated perfusion system that enables novel experimental protocols by allowing recording of any ion channel current, using any cell type, and any compound. The new and improved system retains all the advantages from the previously validated Dynaflow technology and now features the Resolve Glass Chip, providing reusability and adsorption-free perfusion.

"We are very impressed and happy with the data quality the Dynaflow Resolve Glass Chip is providing, both from cell lines and acutely isolated striatal neurons." says Ari-Pekka Koivisto, PhD, Orion Pharma, Finland.

The Dynaflow Resolve chip is made out of glass and has been developed based on customer requirements to minimize adsorption of highly hydrophobic compounds. Besides complete experimental freedom the chip offers reusability and improved cost-efficiency.

"The Dynaflow Resolve chip has solved our problems with difficult compounds and also offers complete flexibility well controlled perfusion and reusability with easy cleaning." Jessica Strömberg, PhD, Umecrine, Umeå, Sweden.

With the launch of the improved Dynaflow Resolve Glass Chip and System, Cellectricon will discontinue the production of the disposable plastic chips by the end of June 2012. Cellectricon offers new and existing customers the ability to take advantage of the benefits of this new technology.

About Cellectricon

Cellectricon, is a leading provider of advanced compound screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable  field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications.

http://www.cellectricon.com


'/>"/>
SOURCE Cellectricon
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
2. Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.
3. Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery
4. Cellectricon Files Patent Infringement Suit Against Fluxion Biosciences
5. David Burns Appointed CEO/President of Cellectricon
6. Hooper Holmes Heritage Labs Division Launches New Home Diabetes Test
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM)
11. ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... 2017 , ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, ... . GGI's mission is to advance global health and highlight the greater good of ... of each clinical trial volunteer. The vision of GGI is to serve as a ...
Breaking Biology Technology:
(Date:2/21/2017)... Ore. , Feb. 22, 2017  IBM (NYSE: ... (Avamere Health Services, Infinity Rehab, Signature Hospice, Home Health, ... will apply the power of IBM cognitive computing to ... centers. By analyzing data streaming from sensors in senior ... and environmental conditions, and obtain deeper learnings into the ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
Breaking Biology News(10 mins):